Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50777 | 0.96 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL27913833 | 0.96 | ALDH1A1 (0.32) | ALDH1A1 | |
| Water SCHEMBL28116863 | 0.92 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL3041911 | 0.92 | ALDH1A1 (0.30) | ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL9328292 | 0.92 | ALDH1A1 (0.30) | ALDH1A1 | |
| Fluoride SCHEMBL23120036 | 0.92 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL6154385 | 0.92 | ALDH1A1 (0.30) | ALDH1A1 | |
| Lithium Ion SCHEMBL10846050 | 0.88 | — | — | |
| SCHEMBL10843317 | 0.88 | — | — | |
| Dimethylamine SCHEMBL3618358 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119080798-A | Preparation method of 4,5,6, 7-tetrahydrothiophene [3,2-c ] pyridine hydrochloride | 杭州永太生物医药有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-111018700-B | Oxocyclo [8] arene derivatives and preparation method thereof | 清华大学 | 2023-03-31 | — | — | CN | claimed |
| CN-115073534-A | Synthetic method of emamectin benzoate | 吴晓明 | 2022-09-20 | — | — | CN | claimed |
| CN-113943330-A | Sugar-containing structure compound, preparation method, pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2022-01-18 | — | — | CN | claimed |
| CN-109734643-B | Method for synthesizing pyrroline compound by catalyzing amino alcohol and enol with iron | 陕西师范大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111018700-A | Oxocyclo [8] arene derivatives and preparation method thereof | 清华大学 | 2020-04-17 | — | — | CN | claimed |
| US-20090176847-A1 | Dicyclooctane Derivatives, Preparation Processes and Medical Uses Thereof | SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) | 2009-07-09 | — | — | US | claimed |
| EP-2006284-A1 | DICYCLOOCTANE DERIVATES, PREPARATION PROCESSES AND MEDICAL USES THEREOF | Shanghai Hengrui Pharmaceutical Co. Ltd. (CN) | 2008-12-24 | — | — | EP | claimed |
| EP-0262061-B1 | PROCESS FOR STABILIZING CHLORINATION MIXTURES OF PHENOL AND/OR CHLOROPHENOLS | RHONE-POULENC CHIMIE (FR) | 1993-02-24 | — | — | EP | claimed |
| US-4853153-A | USING REDUCING AGENT AND CHLORINATED CYCLIC KETONE | RHONE-POULENC CHIMIE (FR) | 1989-08-01 | — | — | US | claimed |
| US-4578482-A | Process for preparing prostacyclins | TEIJIN LIMITED (JP) | 1986-03-25 | — | — | US | claimed |
| EP-0113577-A1 | Process for preparing prostacyclins | TEIJIN LIMITED (JP) | 1984-07-18 | — | — | EP | claimed |
| CN-119504751-A | Bifunctional chimeric heterocyclic compound for targeting and degrading androgen receptor and application thereof | 海创药业股份有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-113683611-B | Novel RET inhibitors, pharmaceutical compositions thereof and uses thereof | 广东东阳光药业股份有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119156383-A | Selective KRAS G12C inhibitors and uses thereof | 1200药业有限责任公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-119080798-A | Preparation method of 4,5,6, 7-tetrahydrothiophene [3,2-c ] pyridine hydrochloride | 杭州永太生物医药有限公司 | 2024-12-06 | — | — | CN | disclosed |
| US-3983158-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3983157-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3980694-A | ANTIULCER, ANTIAGGLOMERANTS, INCREASE OF NASAL PATENCY, LABOR INDUCEMENT, WOUND HEALINGPROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
| US-3931289-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176847-A1 | Dicyclooctane Derivatives, Preparation Processes and Medical Uses Thereof | DPP4, DPP7, DPP8 | ALDH1A1 1142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.